S&P 500

5.346,99

-0,11%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd (BNR) Notícias

BNR

Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BNR

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
03/06/2024	07:08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
03/06/2024	01:41	GlobeNewswire Inc.	Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement	NASDAQ:BNR	Burning Rock Biotech Ltd
30/05/2024	04:42	GlobeNewswire Inc.	Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines	NASDAQ:BNR	Burning Rock Biotech Ltd
29/05/2024	02:34	GlobeNewswire Inc.	Burning Rock Reports First Quarter 2024 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
23/05/2024	03:00	GlobeNewswire Inc.	Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
14/05/2024	03:02	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
29/04/2024	04:30	GlobeNewswire Inc.	Burning Rock Publishes 2023 Annual Report on Form 20-F	NASDAQ:BNR	Burning Rock Biotech Ltd
26/04/2024	02:59	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change	NASDAQ:BNR	Burning Rock Biotech Ltd
28/03/2024	18:16	GlobeNewswire Inc.	Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
14/02/2024	14:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BNR	Burning Rock Biotech Ltd
10/01/2024	18:08	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BNR	Burning Rock Biotech Ltd
04/01/2024	03:03	GlobeNewswire Inc.	Burning Rock Announces Receipt of Notification from NASDAQ	NASDAQ:BNR	Burning Rock Biotech Ltd
19/12/2023	23:35	GlobeNewswire Inc.	Burning Rock Announces Results of 2023 Annual General Meeting	NASDAQ:BNR	Burning Rock Biotech Ltd
30/11/2023	03:25	GlobeNewswire Inc.	Burning Rock Reports Third Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
22/11/2023	04:04	GlobeNewswire Inc.	Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
20/11/2023	22:55	GlobeNewswire Inc.	Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
30/10/2023	04:20	GlobeNewswire Inc.	Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics	NASDAQ:BNR	Burning Rock Biotech Ltd
15/10/2023	20:18	GlobeNewswire Inc.	Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test	NASDAQ:BNR	Burning Rock Biotech Ltd
07/09/2023	23:43	GlobeNewswire Inc.	Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell	NASDAQ:BNR	Burning Rock Biotech Ltd
31/08/2023	02:30	GlobeNewswire Inc.	Burning Rock Reports Second Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
04/08/2023	04:27	GlobeNewswire Inc.	Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
28/06/2023	05:05	GlobeNewswire Inc.	Burning Rock Announces Resignation and Appointment of Directors	NASDAQ:BNR	Burning Rock Biotech Ltd
08/06/2023	01:20	GlobeNewswire Inc.	Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine	NASDAQ:BNR	Burning Rock Biotech Ltd
30/05/2023	07:18	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BNR	Burning Rock Biotech Ltd
30/05/2023	01:53	GlobeNewswire Inc.	Burning Rock Reports First Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
27/04/2023	02:01	GlobeNewswire Inc.	Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
20/04/2023	23:43	GlobeNewswire Inc.	Burning Rock Publishes 2022 Annual Report on Form 20-F	NASDAQ:BNR	Burning Rock Biotech Ltd
20/04/2023	17:05	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:BNR	Burning Rock Biotech Ltd
28/03/2023	03:08	GlobeNewswire Inc.	Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
07/03/2023	05:38	GlobeNewswire Inc.	Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd